There is a reduction in sudden cardiac death risk among patients with heart failure with reduced ejection fraction with an ICD and recent decompensation.

There is a lower risk of 1-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men.